John Wiley & Sons (WLYB) Financials

$43.06 +0.38 (+0.89%)

As of 04/17/2025 03:50 PM Eastern

Annual Income Statements for John Wiley & Sons

This table shows John Wiley & Sons' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Income / (Loss) Attributable to Common Shareholders	177	146	114	192	168	-74	148	148	17	-200
Consolidated Net Income / (Loss)	177	146	114	192	168	-74	148	148	17	-200
Net Income / (Loss) Continuing Operations	177	146	114	192	168	-74	148	148	17	-200
Total Pre-Tax Income	225	175	191	214	213	-63	176	210	33	-187
Total Operating Income	238	188	211	231	224	-54	186	219	56	52
Total Gross Profit	1,323	1,261	1,218	1,265	1,245	1,240	1,316	1,382	1,327	1,293
Total Revenue	1,822	1,727	1,719	1,796	1,800	1,831	1,942	2,083	2,020	1,873
Operating Revenue	1,822	1,727	1,719	1,796	1,800	1,831	1,942	2,083	2,020	1,873
Total Cost of Revenue	500	466	501	531	555	591	625	701	693	580
Operating Cost of Revenue	500	466	501	531	555	591	625	701	693	580
Total Operating Expenses	1,085	1,073	1,006	1,034	1,021	1,295	1,131	1,163	1,271	1,241
Selling, General & Admin Expense	1,005	994	943	953	964	997	1,023	1,080	1,037	1,014
Amortization Expense	51	50	50	48	55	62	75	85	85	56
Impairment Charge	-	-	-	3.60	0.00	202	0.00	0.00	100	108
Restructuring Charge	29	29	13	29	3.12	33	33	-1.43	49	63
Total Other Income / (Expense), net	-12	-13	-20	-18	-11	-8.81	-9.60	-9.62	-23	-239
Interest Expense	17	17	17	13	16	25	18	20	38	49
Other Income / (Expense), net	1.74	0.47	-3.42	-4.26	5.08	16	8.78	10	15	-190
Income Tax Expense	49	29	77	22	45	11	28	61	16	13
Basic Earnings per Share	$3.01	$2.51	$1.98	$3.37	$2.94	($1.32)	$2.65	$2.66	$0.31	($3.65)
Weighted Average Basic Shares Outstanding	58.73M	58.00M	57.34M	57.04M	57.19M	56.21M	55.93M	55.76M	55.56M	54.95M
Diluted Earnings per Share	$2.97	$2.48	$1.95	$3.32	$2.91	($1.32)	$2.63	$2.62	$0.31	($3.65)
Weighted Average Diluted Shares Outstanding	59.59M	58.73M	58.20M	57.89M	57.84M	56.21M	56.46M	56.60M	56.36M	54.95M
Weighted Average Basic & Diluted Shares Outstanding	58.80M	58.10M	57.40M	57M	57.20M	55.86M	55.85M	55.75M	55.28M	54.43M

This table shows John Wiley & Sons' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025
Net Income / (Loss) Attributable to Common Shareholders	-18	38	-71	68	-92	-19	-114	25	-1.44	40	-23
Consolidated Net Income / (Loss)	-18	38	-71	68	-92	-19	-114	25	-1.44	40	-23
Net Income / (Loss) Continuing Operations	-18	38	-71	68	-92	-19	-114	25	-1.44	40	-23
Total Pre-Tax Income	-23	48	-77	86	-107	-22	-112	54	23	49	19
Total Operating Income	-17	57	-67	82	-16	46	-46	69	29	64	52
Total Gross Profit	314	345	317	352	294	337	317	345	295	320	300
Total Revenue	488	515	491	526	451	493	461	468	404	427	405
Operating Revenue	488	515	491	526	451	493	461	468	404	427	405
Total Cost of Revenue	174	170	174	174	157	156	144	123	109	107	104
Operating Cost of Revenue	174	170	174	174	157	156	144	123	109	107	104
Total Operating Expenses	331	287	384	269	310	291	363	276	266	255	249
Selling, General & Admin Expense	283	253	256	246	256	252	253	252	249	239	230
Amortization Expense	25	20	20	19	16	14	14	13	13	13	13
Impairment Charge	0.00	0.00	100	-	27	0.00	82	-	0.00	0.00	0.00
Restructuring Charge	22	14	8.81	4.19	12	25	15	11	3.87	3.63	5.57
Total Other Income / (Expense), net	-6.42	-9.11	-10	3.14	-90	-68	-66	-15	-5.97	-15	-33
Interest Expense	6.33	9.33	12	11	11	13	13	11	13	14	14
Other Income / (Expense), net	-0.09	0.22	1.13	14	-79	-55	-53	-3.37	6.82	-0.73	-19
Income Tax Expense	-5.55	10	-5.98	17	-14	-2.59	1.58	29	24	8.48	42
Basic Earnings per Share	($0.32)	$0.69	($1.29)	$1.23	($1.67)	($0.35)	($2.08)	$0.45	($0.03)	$0.75	($0.43)
Weighted Average Basic Shares Outstanding	55.74M	55.62M	55.51M	55.56M	55.27M	55.10M	54.81M	54.95M	54.38M	54.19M	53.95M
Diluted Earnings per Share	($0.32)	$0.68	($1.29)	$1.24	($1.67)	($0.35)	($2.08)	$0.45	($0.03)	$0.74	($0.43)
Weighted Average Diluted Shares Outstanding	55.74M	56.20M	55.51M	56.36M	55.27M	55.10M	54.81M	54.95M	54.38M	54.85M	53.95M
Weighted Average Basic & Diluted Shares Outstanding	55.70M	55.56M	55.45M	55.28M	55.21M	54.87M	54.73M	54.43M	54.28M	54.03M	53.85M

This table details how cash moves in and out of John Wiley & Sons' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Change in Cash & Equivalents	-29	-94	-305	108	-77	109	-109	6.37	6.54	-7.72
Net Cash From Operating Activities	355	350	315	382	251	288	360	339	277	208
Net Cash From Continuing Operating Activities	355	350	315	382	251	288	360	339	277	208
Net Income / (Loss) Continuing Operations	177	146	114	192	168	-74	148	148	17	-200
Consolidated Net Income / (Loss)	177	146	114	192	168	-74	148	148	17	-200
Depreciation Expense	62	66	67	64	69	77	91	95	96	98
Amortization Expense	202	199	205	206	92	98	109	120	117	79
Non-Cash Adjustments To Reconcile Net Income	49	58	95	34	21	270	111	80	185	398
Changes in Operating Assets and Liabilities, net	-134	-119	-165	-114	-99	-83	-100	-104	-139	-167
Net Cash From Investing Activities	-280	-151	-243	-177	-302	-347	-433	-194	-98	-107
Net Cash From Continuing Investing Activities	-280	-151	-243	-177	-302	-347	-433	-194	-98	-107
Purchase of Property, Plant & Equipment	-69	-86	-105	-114	-77	-89	-77	-89	-81	-76
Acquisitions	-172	-20	-155	-27	-200	-231	-330	-82	-9.87	-13
Sale of Property, Plant & Equipment	-	-	-	-	-	0.00	0.00	3.38	16	0.00
Other Investing Activities, net	-38	-45	-44	-37	-24	-27	-26	-27	-23	-17
Net Cash From Financing Activities	-61	-286	-346	-97	-18	173	-47	-132	-169	-107
Net Cash From Continuing Financing Activities	-61	-286	-346	-97	-18	173	-47	-132	-169	-107
Repayment of Debt	-718	-613	-923	-472	-482	-635	-544	-668	-1,054	-1,161
Repurchase of Common Equity	-62	-70	-50	-40	-60	-47	-16	-30	-35	-45
Payment of Dividends	-68	-70	-72	-74	-76	-77	-77	-77	-77	-77
Issuance of Debt	759	467	683	459	596	934	593	651	1,005	1,185
Other Financing Activities, net	29	0.93	16	29	3.75	-3.79	-3.43	-7.11	-8.00	-8.50
Other Net Changes in Cash	-	-	-31	-	-	-4.94	12	-7.07	-3.57	-1.49
Cash Interest Paid	15	15	16	12	15	24	17	18	36	47
Cash Income Taxes Paid	46	39	34	49	48	42	41	49	51	51

This table details how cash moves in and out of John Wiley & Sons' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025
Net Change in Cash & Equivalents	4.26	14	7.93	-20	-0.01	-7.64	9.29	-9.36	-10	-14	29
Net Cash From Operating Activities	-90	14	130	223	-82	-1.15	108	183	-89	-5.28	146
Net Cash From Continuing Operating Activities	-90	14	130	223	-82	-1.15	108	183	-89	-5.28	146
Net Income / (Loss) Continuing Operations	-18	38	-71	68	-92	-19	-114	25	-1.44	40	-23
Consolidated Net Income / (Loss)	-18	38	-71	68	-92	-19	-114	25	-1.44	40	-23
Depreciation Expense	25	24	24	23	21	20	27	29	20	20	19
Amortization Expense	34	28	29	27	22	20	18	18	17	17	17
Non-Cash Adjustments To Reconcile Net Income	28	29	115	14	111	74	153	60	14	25	38
Changes in Operating Assets and Liabilities, net	-158	-106	34	91	-145	-96	24	50	-139	-107	95
Net Cash From Investing Activities	-22	-26	-32	-18	-26	-26	-27	-28	-24	-21	-25
Net Cash From Continuing Investing Activities	-22	-26	-32	-18	-26	-26	-27	-28	-24	-21	-25
Purchase of Property, Plant & Equipment	-18	-21	-19	-24	-20	-20	-17	-19	-15	-15	-13
Acquisitions	-0.10	-	-5.70	-4.08	-1.50	-	-2.85	-10	-7.30	-1.73	-3.12
Other Investing Activities, net	-3.79	-5.92	-7.00	-6.25	-4.61	-6.51	-5.74	-0.40	-2.00	-4.42	-8.77
Net Cash From Financing Activities	118	34	-96	-224	106	24	-74	-163	102	11	-89
Net Cash From Continuing Financing Activities	118	34	-96	-224	106	24	-74	-163	102	11	-89
Repayment of Debt	-116	-108	-270	-558	-202	-182	-368	-409	-313	-312	-301
Repurchase of Common Equity	-10	-7.50	-6.50	-11	-10	-13	-6.50	-16	-13	-13	-10
Payment of Dividends	-19	-19	-19	-19	-19	-19	-19	-19	-19	-19	-19
Issuance of Debt	269	169	201	367	342	238	320	285	450	356	241
Other Financing Activities, net	-4.72	-0.04	-0.71	-2.53	-4.33	-0.28	-0.91	-2.99	-3.75	-0.22	-0.16
Other Net Changes in Cash	-1.99	-6.80	6.11	-0.90	2.26	-4.20	2.38	-1.93	0.80	0.64	-3.06
Cash Interest Paid	5.51	8.57	12	10	11	12	13	11	12	14	14
Cash Income Taxes Paid	14	11	13	12	12	14	12	12	9.17	20	14

This table presents John Wiley & Sons' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total Assets	3,004	2,921	2,606	2,839	2,949	3,169	3,446	3,362	3,109	2,725
Total Current Assets	741	671	360	480	503	615	526	551	541	454
Cash & Equivalents	457	364	59	170	93	202	94	100	107	83
Accounts Receivable	147	168	189	212	307	309	312	332	310	224
Inventories, net	64	58	48	39	36	44	43	37	31	26
Prepaid Expenses	73	81	65	58	67	59	78	82	94	86
Other Current Nonoperating Assets	-	-	-	-	-	-	-	-	0.00	34
Plant, Property, & Equipment, net	193	215	243	290	289	298	282	272	247	192
Total Noncurrent Assets	2,070	2,036	2,003	2,070	2,157	2,256	2,638	2,539	2,320	2,079
Goodwill	962	952	982	1,020	1,096	1,117	1,304	1,302	1,204	1,091
Intangible Assets	918	877	828	848	866	807	1,015	931	855	616
Other Noncurrent Operating Assets	133	144	193	202	196	332	318	306	262	353
Other Noncurrent Nonoperating Assets	-	-	-	-	-	-	-	-	0.00	19
Total Liabilities & Shareholders' Equity	3,004	2,921	2,606	2,839	2,949	3,169	3,446	3,362	3,109	2,725
Total Liabilities	1,949	1,884	1,603	1,649	1,767	2,235	2,355	2,219	2,064	1,986
Total Current Liabilities	804	782	788	874	882	927	989	969	896	873
Short-Term Debt	100	-	-	-	0.00	9.38	13	19	5.00	7.50
Accounts Payable	161	166	76	90	91	94	96	77	84	56
Accrued Expenses	-	-	63	73	78	87	79	102	113	97
Current Deferred Revenue	372	426	436	-	-	-	-	538	-	484
Current Employee Benefit Liabilities	99	103	104	116	97	108	145	117	80	97
Other Current Liabilities	62	76	86	581	595	615	657	116	612	95
Other Current Nonoperating Liabilities	-	-	-	-	-	-	-	-	0.00	38
Total Noncurrent Liabilities	1,146	1,102	815	775	885	1,308	1,366	1,250	1,312	1,112
Long-Term Debt	650	605	365	360	479	766	809	768	743	767
Noncurrent Deferred & Payable Income Tax Liabilities	199	190	160	144	144	119	173	180	288	97
Noncurrent Employee Benefit Liabilities	210	224	215	190	166	188	146	79	86	71
Other Noncurrent Operating Liabilities	87	83	75	81	96	235	238	223	195	166
Other Noncurrent Nonoperating Liabilities	-	-	-	-	-	-	-	-	0.00	11
Commitments & Contingencies	-	-	-	-	-	-	-	-	0.00	0.00
Total Equity & Noncontrolling Interests	1,055	1,037	1,003	1,191	1,181	850	1,091	1,142	1,045	740
Total Preferred & Common Equity	1,055	1,037	1,003	1,191	1,181	934	1,091	1,142	1,045	740
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	1,055	1,037	1,003	1,191	1,181	850	1,091	1,139	1,045	740
Common Stock	436	452	471	490	505	432	528	542	553	558
Retained Earnings	1,597	1,673	1,715	1,834	1,931	1,780	1,850	1,921	1,861	1,583
Treasury Stock	-572	-640	-676	-694	-746	-786	-796	-813	-840	-873
Accumulated Other Comprehensive Income / (Loss)	-407	-448	-507	-440	-509	-575	-491	-512	-529	-528

This table presents John Wiley & Sons' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025
Total Assets	3,378	3,229	3,128	3,150	2,926	2,779	2,707	2,652	2,609	2,600
Total Current Assets	492	501	483	531	478	426	384	393	370	395
Cash & Equivalents	109	104	118	126	75	83	93	83	76	105
Accounts Receivable	268	281	260	284	153	147	161	192	183	185
Inventories, net	40	33	34	33	30	30	28	26	27	25
Prepaid Expenses	74	81	70	88	80	59	69	87	85	80
Other Current Nonoperating Assets	-	-	-	-	139	106	33	5.28	0.00	0.00
Plant, Property, & Equipment, net	272	258	250	248	224	223	208	185	172	165
Total Noncurrent Assets	2,614	2,470	2,395	2,371	2,225	2,131	2,115	2,074	2,066	2,041
Goodwill	1,326	1,289	1,268	1,203	1,102	1,082	1,097	1,100	1,102	1,079
Intangible Assets	971	896	861	868	657	631	629	609	598	572
Other Noncurrent Operating Assets	318	285	267	299	224	216	370	365	366	389
Other Noncurrent Nonoperating Assets	-	-	-	-	241	203	19	0.02	0.00	0.00
Total Liabilities & Shareholders' Equity	3,378	3,229	3,128	3,150	2,926	2,779	2,707	2,652	2,609	2,600
Total Liabilities	2,258	2,147	2,051	2,123	1,989	1,912	1,959	1,938	1,854	1,915
Total Current Liabilities	821	781	635	761	706	610	712	689	561	717
Short-Term Debt	16	22	44	5.00	5.00	5.00	6.25	8.75	10	10
Accounts Payable	77	57	46	32	44	49	45	39	40	53
Accrued Expenses	141	94	102	154	99	106	151	105	119	156
Current Deferred Revenue	-	-	-	369	370	236	301	367	241	313
Current Employee Benefit Liabilities	105	80	84	81	52	83	78	49	61	74
Other Current Liabilities	466	528	358	119	86	90	97	96	90	110
Other Current Nonoperating Liabilities	-	-	-	-	50	42	34	24	0.00	0.00
Total Noncurrent Liabilities	1,437	1,366	1,416	1,362	1,283	1,302	1,247	1,250	1,292	1,197
Long-Term Debt	902	917	979	941	891	938	901	910	951	877
Noncurrent Deferred & Payable Income Tax Liabilities	183	160	157	145	110	94	95	97	99	95
Noncurrent Employee Benefit Liabilities	116	78	76	78	81	76	72	68	71	70
Other Noncurrent Operating Liabilities	236	212	205	199	185	180	169	169	171	156
Other Noncurrent Nonoperating Liabilities	-	-	-	-	15	14	9.70	5.97	0.00	0.00
Commitments & Contingencies	-	-	-	-	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	1,120	1,082	1,078	1,027	937	867	748	714	755	685
Total Preferred & Common Equity	1,120	1,082	1,078	1,027	937	867	748	714	755	685
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	1,120	1,082	1,078	1,027	937	867	748	714	755	685
Common Stock	540	542	548	553	548	554	557	556	562	566
Retained Earnings	1,897	1,884	1,903	1,812	1,749	1,710	1,577	1,563	1,584	1,542
Treasury Stock	-811	-820	-827	-832	-843	-855	-860	-882	-894	-903
Accumulated Other Comprehensive Income / (Loss)	-507	-523	-546	-506	-517	-542	-527	-524	-496	-519

This table displays calculated financial ratios and metrics derived from John Wiley & Sons' official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	2.66%	-5.23%	-0.49%	4.51%	0.22%	1.75%	6.01%	7.28%	-3.03%	-7.27%
EBITDA Growth	8.25%	-9.92%	5.67%	3.87%	-21.61%	-64.89%	187.96%	12.71%	-36.11%	-86.29%
EBIT Growth	14.34%	-21.25%	10.32%	9.20%	0.82%	-116.65%	609.52%	18.10%	-69.13%	-294.85%
NOPAT Growth	9.93%	-15.88%	-19.85%	65.36%	-14.88%	-121.47%	511.43%	-0.79%	-81.24%	25.72%
Net Income Growth	10.19%	-17.58%	-22.05%	69.11%	-12.45%	-144.15%	299.57%	0.04%	-88.38%	-1,262.42%
EPS Growth	10.00%	-16.50%	-21.37%	70.26%	-12.35%	-145.36%	299.24%	-0.38%	-88.17%	-1,277.42%
Operating Cash Flow Growth	1.98%	-1.45%	-10.02%	21.41%	-34.39%	14.99%	24.78%	-5.79%	-18.29%	-25.06%
Free Cash Flow Firm Growth	132.69%	-3.62%	-58.27%	44.84%	-106.93%	343.28%	-778.86%	192.81%	117.10%	-17.94%
Invested Capital Growth	-3.46%	-5.15%	2.45%	5.43%	13.50%	-3.90%	20.77%	0.54%	-15.66%	-14.41%
Revenue Q/Q Growth	-0.84%	-0.42%	1.05%	1.41%	0.78%	-0.90%	3.28%	0.45%	-0.96%	-2.99%
EBITDA Q/Q Growth	2.02%	-1.68%	4.88%	2.93%	-23.10%	-63.93%	389.00%	0.42%	14.86%	-46.06%
EBIT Q/Q Growth	2.95%	-6.15%	11.26%	7.87%	4.27%	-117.84%	950.27%	0.93%	124.84%	-28.67%
NOPAT Q/Q Growth	6.91%	-7.49%	14.77%	-0.02%	5.63%	-124.01%	712.59%	3.90%	30.52%	-20.76%
Net Income Q/Q Growth	6.64%	-8.01%	12.31%	4.00%	5.77%	-150.54%	390.03%	1.24%	316.36%	-27.40%
EPS Q/Q Growth	6.83%	-7.81%	12.72%	4.08%	5.82%	-151.36%	392.22%	1.16%	282.35%	-27.62%
Operating Cash Flow Q/Q Growth	1.88%	10.19%	-31.91%	38.31%	2.88%	0.30%	1.57%	-6.73%	18.24%	-16.18%
Free Cash Flow Firm Q/Q Growth	103.31%	-4.78%	-40.86%	1.69%	84.29%	200.96%	-92.31%	-6.12%	203.27%	-23.59%
Invested Capital Q/Q Growth	-10.92%	-11.53%	-6.11%	-5.96%	-7.60%	-19.77%	-5.90%	-5.13%	-16.44%	-15.01%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	72.58%	73.01%	70.86%	70.43%	69.18%	67.73%	67.79%	66.36%	65.71%	69.05%
EBITDA Margin	27.63%	26.26%	27.89%	27.72%	21.68%	7.48%	20.32%	21.35%	14.07%	2.08%
Operating Margin	13.05%	10.89%	12.31%	12.89%	12.44%	-2.96%	9.56%	10.53%	2.77%	2.79%
EBIT Margin	13.14%	10.92%	12.11%	12.65%	12.73%	-2.08%	10.01%	11.02%	3.51%	-7.37%
Profit (Net Income) Margin	9.71%	8.44%	6.61%	10.70%	9.35%	-4.06%	7.64%	7.12%	0.85%	-10.70%
Tax Burden Percent	78.45%	83.40%	59.46%	89.84%	79.01%	117.74%	84.28%	70.74%	52.06%	107.10%
Interest Burden Percent	94.15%	92.69%	91.86%	94.16%	92.96%	165.45%	90.54%	91.37%	46.72%	135.50%
Effective Tax Rate	21.55%	16.60%	40.54%	10.16%	20.99%	0.00%	15.72%	29.26%	47.94%	0.00%
Return on Invested Capital (ROIC)	13.60%	11.95%	9.72%	15.46%	12.01%	-2.47%	9.40%	8.50%	1.73%	2.56%
ROIC Less NNEP Spread (ROIC-NNEP)	9.79%	7.79%	5.30%	9.12%	8.98%	-9.44%	8.23%	7.54%	-0.28%	-41.39%
Return on Net Nonoperating Assets (RNNOA)	2.22%	1.99%	1.42%	2.06%	2.18%	-4.84%	5.87%	4.78%	-0.15%	-25.00%
Return on Equity (ROE)	15.81%	13.94%	11.14%	17.52%	14.19%	-7.31%	15.27%	13.28%	1.58%	-22.45%
Cash Return on Invested Capital (CROIC)	17.11%	17.23%	7.30%	10.17%	-0.64%	1.50%	-9.42%	7.97%	18.71%	18.08%
Operating Return on Assets (OROA)	7.88%	6.37%	7.53%	8.34%	7.92%	-1.25%	5.87%	6.74%	2.19%	-4.73%
Return on Assets (ROA)	5.82%	4.92%	4.11%	7.06%	5.81%	-2.43%	4.48%	4.36%	0.53%	-6.87%
Return on Common Equity (ROCE)	15.81%	13.94%	11.14%	17.52%	14.19%	-7.31%	15.27%	13.26%	1.57%	-22.45%
Return on Equity Simple (ROE_SIMPLE)	16.76%	14.06%	11.33%	16.14%	14.24%	-7.96%	13.59%	12.98%	1.65%	-27.08%
Net Operating Profit after Tax (NOPAT)	186	157	126	208	177	-38	156	155	29	37
NOPAT Margin	10.23%	9.08%	7.32%	11.58%	9.83%	-2.07%	8.05%	7.45%	1.44%	1.95%
Net Nonoperating Expense Percent (NNEP)	3.80%	4.16%	4.42%	6.34%	3.03%	6.97%	1.17%	0.96%	2.00%	43.95%
Cost of Revenue to Revenue	27.42%	26.99%	29.14%	29.57%	30.82%	32.27%	32.21%	33.64%	34.29%	30.95%
SG&A Expenses to Revenue	55.15%	57.58%	54.89%	53.07%	53.53%	54.46%	52.67%	51.83%	51.36%	54.11%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	59.54%	62.11%	58.55%	57.55%	56.74%	70.69%	58.24%	55.83%	62.95%	66.26%
Earnings before Interest and Taxes (EBIT)	239	189	208	227	229	-38	194	229	71	-138
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	503	454	479	498	390	137	394	445	284	39
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.41	2.15	2.40	2.59	1.89	2.15	2.62	2.29	1.95	2.76
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	1.39	1.29	1.40	1.72	1.24	1.00	1.47	1.25	1.01	1.09
Price to Earnings (P/E)	14.35	15.30	21.21	16.07	13.24	0.00	19.28	17.61	118.30	0.00
Dividend Yield	2.68%	3.11%	3.66%	2.38%	4.24%	4.17%	2.68%	2.94%	3.78%	3.76%
Earnings Yield	6.97%	6.54%	4.71%	6.22%	7.55%	0.00%	5.19%	5.68%	0.85%	0.00%
Enterprise Value to Invested Capital (EV/IC)	2.10	1.93	2.07	2.37	1.67	1.60	1.97	1.80	1.74	2.07
Enterprise Value to Revenue (EV/Rev)	1.55	1.43	1.58	1.83	1.45	1.31	1.85	1.58	1.33	1.46
Enterprise Value to EBITDA (EV/EBITDA)	5.62	5.45	5.67	6.59	6.70	17.54	9.09	7.42	9.43	70.14
Enterprise Value to EBIT (EV/EBIT)	11.82	13.11	13.06	14.43	11.41	0.00	18.46	14.37	37.83	0.00
Enterprise Value to NOPAT (EV/NOPAT)	15.18	15.75	21.61	15.77	14.77	0.00	22.94	21.26	92.11	74.67
Enterprise Value to Operating Cash Flow (EV/OCF)	7.97	7.06	8.63	8.57	10.42	8.33	9.96	9.73	9.67	13.16
Enterprise Value to Free Cash Flow (EV/FCFF)	12.06	10.92	28.77	23.97	0.00	104.18	0.00	22.70	8.50	10.55
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.71	0.58	0.36	0.30	0.41	0.91	0.75	0.69	0.72	1.05
Long-Term Debt to Equity	0.62	0.58	0.36	0.30	0.41	0.90	0.74	0.67	0.71	1.04
Financial Leverage	0.23	0.26	0.27	0.23	0.24	0.51	0.71	0.63	0.54	0.60
Leverage Ratio	2.72	2.83	2.71	2.48	2.44	3.01	3.41	3.05	2.96	3.27
Compound Leverage Factor	2.56	2.63	2.49	2.34	2.27	4.98	3.08	2.79	1.38	4.43
Debt to Total Capital	41.55%	36.84%	26.68%	23.22%	28.84%	47.68%	42.95%	40.79%	41.73%	51.15%
Short-Term Debt to Total Capital	5.54%	0.00%	0.00%	0.00%	0.00%	0.58%	0.65%	0.97%	0.28%	0.50%
Long-Term Debt to Total Capital	36.01%	36.84%	26.68%	23.22%	28.84%	47.10%	42.30%	39.82%	41.45%	50.66%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	58.45%	63.16%	73.32%	76.78%	71.16%	52.32%	57.05%	59.02%	58.27%	48.85%
Debt to EBITDA	1.49	1.33	0.76	0.72	1.23	5.66	2.08	1.77	2.63	19.89
Net Debt to EBITDA	0.58	0.53	0.64	0.38	0.99	4.18	1.84	1.54	2.26	17.75
Long-Term Debt to EBITDA	1.29	1.33	0.76	0.72	1.23	5.59	2.05	1.73	2.62	19.70
Debt to NOPAT	4.02	3.86	2.90	1.73	2.71	-20.39	5.25	5.07	25.72	21.17
Net Debt to NOPAT	1.57	1.54	2.44	0.91	2.18	-15.07	4.66	4.43	22.05	18.90
Long-Term Debt to NOPAT	3.49	3.86	2.90	1.73	2.71	-20.15	5.18	4.95	25.54	20.97
Altman Z-Score	2.37	2.27	2.55	2.76	2.39	1.70	2.07	2.20	2.02	1.77
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.16%	0.17%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.92	0.86	0.46	0.55	0.57	0.66	0.53	0.57	0.60	0.52
Quick Ratio	0.75	0.68	0.31	0.44	0.45	0.55	0.41	0.45	0.47	0.35
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	235	226	94	137	-9.48	23	-157	145	315	259
Operating Cash Flow to CapEx	513.77%	405.05%	299.74%	334.71%	325.05%	325.57%	464.97%	396.76%	422.56%	272.92%
Free Cash Flow to Firm to Interest Expense	13.75	13.54	5.58	10.30	-0.59	0.92	-8.52	7.34	8.36	5.28
Operating Cash Flow to Interest Expense	20.80	20.95	18.59	28.80	15.56	11.56	19.58	17.12	7.34	4.24
Operating Cash Flow Less CapEx to Interest Expense	16.75	15.78	12.39	20.20	10.77	8.01	15.37	12.81	5.60	2.68
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.60	0.58	0.62	0.66	0.62	0.60	0.59	0.61	0.62	0.64
Accounts Receivable Turnover	12.28	10.97	9.65	8.96	6.94	5.95	6.25	6.47	6.29	7.01
Inventory Turnover	7.18	7.67	9.48	12.16	14.78	14.93	14.52	17.71	20.58	20.36
Fixed Asset Turnover	9.55	8.47	7.51	6.74	6.22	6.24	6.69	7.52	7.79	8.52
Accounts Payable Turnover	3.29	2.85	4.13	6.38	6.13	6.40	6.60	8.09	8.56	8.28
Days Sales Outstanding (DSO)	29.73	33.27	37.84	40.75	52.62	61.38	58.37	56.38	58.01	52.06
Days Inventory Outstanding (DIO)	50.87	47.59	38.49	30.02	24.70	24.45	25.14	20.61	17.74	17.93
Days Payable Outstanding (DPO)	111.03	128.28	88.39	57.20	59.57	57.02	55.30	45.12	42.63	44.07
Cash Conversion Cycle (CCC)	-30.43	-47.43	-12.06	13.57	17.74	28.81	28.21	31.87	33.12	25.92
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,348	1,278	1,310	1,381	1,567	1,506	1,819	1,829	1,543	1,320
Invested Capital Turnover	1.33	1.32	1.33	1.34	1.22	1.19	1.17	1.14	1.20	1.31
Increase / (Decrease) in Invested Capital	-48	-69	31	71	186	-61	313	9.82	-286	-222
Enterprise Value (EV)	2,831	2,472	2,717	3,278	2,614	2,403	3,586	3,298	2,680	2,732
Market Capitalization	2,538	2,230	2,411	3,088	2,228	1,830	2,858	2,611	2,039	2,040
Book Value per Share	$17.97	$17.97	$17.49	$20.74	$20.66	$15.17	$19.53	$20.44	$18.85	$13.51
Tangible Book Value per Share	($14.05)	($13.71)	($14.08)	($11.80)	($13.64)	($19.15)	($21.99)	($19.65)	($18.28)	($17.67)
Total Capital	1,805	1,642	1,368	1,551	1,660	1,625	1,913	1,929	1,793	1,514
Total Debt	750	605	365	360	479	775	822	787	748	775
Total Long-Term Debt	650	605	365	360	479	766	809	768	743	767
Net Debt	293	241	306	190	386	573	728	687	642	691
Capital Expenditures (CapEx)	69	86	105	114	77	89	77	85	66	76
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-420	-475	-487	-564	-473	-505	-544	-500	-456	-495
Debt-free Net Working Capital (DFNWC)	37	-111	-428	-394	-380	-303	-450	-400	-349	-412
Net Working Capital (NWC)	-63	-111	-428	-394	-380	-312	-463	-419	-354	-419
Net Nonoperating Expense (NNE)	9.63	11	12	16	8.72	36	8.09	6.80	12	237
Net Nonoperating Obligations (NNO)	293	241	306	190	386	656	728	687	498	581
Total Depreciation and Amortization (D&A)	264	265	271	271	161	175	200	215	213	177
Debt-free, Cash-free Net Working Capital to Revenue	-23.06%	-27.50%	-28.32%	-31.41%	-26.26%	-27.60%	-28.02%	-24.01%	-22.57%	-26.43%
Debt-free Net Working Capital to Revenue	2.04%	-6.43%	-24.91%	-21.96%	-21.10%	-16.54%	-23.19%	-19.19%	-17.29%	-21.98%
Net Working Capital to Revenue	-3.44%	-6.43%	-24.91%	-21.96%	-21.10%	-17.05%	-23.83%	-20.09%	-17.54%	-22.38%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$3.01	$2.51	$1.98	$3.37	$2.94	($1.32)	$2.65	$2.66	$0.31	($3.65)
Adjusted Weighted Average Basic Shares Outstanding	58.73M	58.00M	57.34M	57.04M	57.19M	56.21M	55.93M	55.76M	55.56M	54.95M
Adjusted Diluted Earnings per Share	$2.97	$2.48	$1.95	$3.32	$2.91	($1.32)	$2.63	$2.62	$0.31	($3.65)
Adjusted Weighted Average Diluted Shares Outstanding	59.59M	58.73M	58.20M	57.89M	57.84M	56.21M	56.46M	56.60M	56.36M	54.95M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$2.94	($1.32)	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	58.86M	57.58M	57.20M	57.50M	56.63M	55.86M	55.85M	55.75M	55.28M	54.43M
Normalized Net Operating Profit after Tax (NOPAT)	209	181	134	237	179	126	184	154	107	157
Normalized NOPAT Margin	11.47%	10.47%	7.78%	13.19%	9.97%	6.91%	9.50%	7.40%	5.29%	8.36%
Pre Tax Income Margin	12.37%	10.12%	11.12%	11.91%	11.83%	-3.44%	9.06%	10.07%	1.64%	-9.99%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	14.02	11.29	12.28	17.12	14.21	-1.53	10.57	11.59	1.88	-2.82
NOPAT to Interest Expense	10.92	9.39	7.42	15.66	10.98	-1.52	8.50	7.83	0.77	0.75
EBIT Less CapEx to Interest Expense	9.98	6.12	6.08	8.51	9.42	-5.08	6.36	7.27	0.14	-4.37
NOPAT Less CapEx to Interest Expense	6.87	4.22	1.22	7.06	6.19	-5.07	4.29	3.52	-0.97	-0.81
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	38.73%	47.95%	62.96%	38.27%	45.02%	-103.19%	51.90%	52.06%	448.55%	-38.42%
Augmented Payout Ratio	73.77%	95.95%	107.24%	58.92%	80.67%	-165.91%	62.53%	72.28%	651.65%	-60.91%

This table displays calculated financial ratios and metrics derived from John Wiley & Sons' official financial filings.

Metric	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-0.17%	-3.41%	-4.75%	-3.58%	-7.50%	-4.28%	-6.24%	-10.96%	-10.47%	-13.44%	-12.17%
EBITDA Growth	-60.06%	-15.47%	-113.26%	33.57%	-225.32%	-71.77%	-296.66%	-22.73%	241.39%	222.12%	229.29%
EBIT Growth	-135.06%	-23.80%	-236.44%	69.21%	-459.30%	-115.77%	-50.12%	-31.98%	137.52%	797.24%	133.04%
NOPAT Growth	-192.23%	-22.49%	-224.73%	35.35%	3.60%	-28.68%	30.79%	-51.12%	84.20%	63.79%	-96.12%
Net Income Growth	-228.96%	-31.76%	-302.08%	58.40%	-417.32%	-150.91%	-59.33%	-63.03%	98.44%	308.06%	79.84%
EPS Growth	-233.33%	-31.31%	-304.76%	63.16%	-421.88%	-151.47%	-61.24%	-63.71%	98.20%	311.43%	79.33%
Operating Cash Flow Growth	-6.09%	50.16%	-44.51%	23.66%	8.45%	-108.38%	-16.99%	-17.94%	-7.75%	-358.73%	35.61%
Free Cash Flow Firm Growth	113.46%	151.77%	-19.33%	806.95%	1,411.37%	374.67%	647.87%	-27.75%	-128.88%	-121.17%	-91.62%
Invested Capital Growth	-2.17%	-3.35%	-4.24%	-15.66%	-24.74%	-25.68%	-15.85%	-14.41%	9.14%	11.38%	-5.50%
Revenue Q/Q Growth	-10.64%	5.59%	-4.56%	7.07%	-14.28%	9.27%	-6.51%	1.68%	-13.80%	5.64%	-5.15%
EBITDA Q/Q Growth	-62.36%	167.04%	-112.25%	1,184.51%	-135.32%	160.16%	-272.13%	311.26%	-35.38%	37.07%	-30.91%
EBIT Q/Q Growth	-130.01%	438.09%	-214.34%	245.86%	-199.19%	90.47%	-988.47%	166.09%	-45.29%	77.14%	-48.42%
NOPAT Q/Q Growth	-124.41%	482.23%	-203.41%	240.27%	-117.39%	382.76%	-200.36%	199.05%	-105.62%	3,031.47%	-220.17%
Net Income Q/Q Growth	-141.34%	314.15%	-287.13%	195.63%	-235.00%	78.92%	-485.63%	122.19%	-105.68%	2,917.41%	-156.74%
EPS Q/Q Growth	-142.11%	312.50%	-289.71%	196.12%	-234.68%	79.04%	-494.29%	121.63%	-106.67%	2,566.67%	-158.11%
Operating Cash Flow Q/Q Growth	-149.80%	115.28%	845.31%	71.92%	-136.86%	98.60%	9,469.07%	69.96%	-148.40%	94.05%	2,869.73%
Free Cash Flow Firm Q/Q Growth	-21.13%	272.41%	-69.51%	912.65%	31.43%	16.96%	-51.96%	-2.17%	-152.53%	14.26%	119.01%
Invested Capital Q/Q Growth	4.81%	3.40%	-6.87%	-16.44%	-6.48%	2.11%	5.45%	-15.01%	19.25%	4.21%	-10.53%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	64.31%	66.92%	64.58%	66.90%	65.17%	68.42%	68.82%	73.67%	72.95%	74.92%	74.24%
EBITDA Margin	8.46%	21.38%	-2.75%	27.80%	-11.45%	6.31%	-11.61%	24.13%	18.09%	23.47%	17.10%
Operating Margin	-3.48%	11.16%	-13.65%	15.68%	-3.63%	9.38%	-10.07%	14.68%	7.17%	15.03%	12.81%
EBIT Margin	-3.50%	11.20%	-13.42%	18.28%	-21.15%	-1.85%	-21.48%	13.96%	8.86%	14.86%	8.08%
Profit (Net Income) Margin	-3.66%	7.42%	-14.54%	12.99%	-20.46%	-3.95%	-24.72%	5.39%	-0.36%	9.48%	-5.67%
Tax Burden Percent	76.26%	79.03%	92.28%	79.83%	86.45%	88.27%	101.41%	46.79%	-6.24%	82.67%	-122.93%
Interest Burden Percent	137.13%	83.82%	117.47%	89.02%	111.88%	242.27%	113.46%	82.56%	64.27%	77.19%	57.10%
Effective Tax Rate	0.00%	20.97%	0.00%	20.17%	0.00%	0.00%	0.00%	53.21%	106.24%	17.33%	222.93%
Return on Invested Capital (ROIC)	-2.62%	9.02%	-10.33%	14.99%	-3.00%	7.46%	-8.01%	8.99%	-0.54%	14.05%	-17.76%
ROIC Less NNEP Spread (ROIC-NNEP)	-3.31%	8.25%	-13.34%	15.42%	-15.06%	0.59%	-18.03%	7.71%	-0.49%	12.36%	-12.62%
Return on Net Nonoperating Assets (RNNOA)	-2.63%	6.98%	-10.11%	8.35%	-9.99%	0.46%	-16.50%	4.65%	-0.40%	11.36%	-13.98%
Return on Equity (ROE)	-5.25%	16.00%	-20.44%	23.34%	-12.99%	7.92%	-24.51%	13.64%	-0.95%	25.41%	-31.74%
Cash Return on Invested Capital (CROIC)	9.02%	9.33%	5.51%	18.71%	30.59%	31.30%	19.93%	18.08%	-4.21%	-37.72%	9.70%
Operating Return on Assets (OROA)	-2.21%	7.14%	-8.38%	11.41%	-13.63%	-1.23%	-14.16%	8.97%	5.80%	9.71%	5.19%
Return on Assets (ROA)	-2.31%	4.73%	-9.09%	8.11%	-13.18%	-2.62%	-16.29%	3.46%	-0.23%	6.19%	-3.64%
Return on Common Equity (ROCE)	-5.25%	16.00%	-20.44%	23.30%	-12.99%	7.92%	-24.51%	13.64%	-0.95%	25.41%	-31.74%
Return on Equity Simple (ROE_SIMPLE)	10.78%	9.17%	-0.78%	0.00%	-6.10%	-13.24%	-21.01%	0.00%	-15.34%	-6.57%	6.03%
Net Operating Profit after Tax (NOPAT)	-12	45	-47	66	-11	32	-32	32	-1.81	53	-64
NOPAT Margin	-2.44%	8.82%	-9.55%	12.51%	-2.54%	6.57%	-7.05%	6.87%	-0.45%	12.43%	-15.75%
Net Nonoperating Expense Percent (NNEP)	0.69%	0.78%	3.01%	-0.42%	12.06%	6.86%	10.02%	1.28%	-0.05%	1.68%	-5.13%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-1.96%	-	-	-	-4.05%
Cost of Revenue to Revenue	35.69%	33.08%	35.42%	33.10%	34.83%	31.58%	31.18%	26.33%	27.05%	25.08%	25.76%
SG&A Expenses to Revenue	57.99%	49.15%	52.06%	46.72%	56.72%	51.19%	55.00%	53.81%	61.62%	56.00%	56.83%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	67.79%	55.76%	78.23%	51.22%	68.79%	59.04%	78.89%	58.99%	65.78%	59.88%	61.43%
Earnings before Interest and Taxes (EBIT)	-17	58	-66	96	-95	-9.09	-99	65	36	63	33
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	41	110	-13	146	-52	31	-54	113	73	100	69
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.50	2.04	2.34	1.95	1.94	1.86	2.40	2.76	3.64	3.54	3.23
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	1.30	1.07	1.18	1.01	0.92	0.82	0.93	1.09	1.42	1.52	1.30
Price to Earnings (P/E)	23.16	22.25	0.00	118.30	0.00	0.00	0.00	0.00	0.00	0.00	53.50
Dividend Yield	2.85%	3.51%	3.21%	3.78%	4.22%	4.77%	4.26%	3.76%	2.94%	2.85%	3.44%
Earnings Yield	4.32%	4.49%	0.00%	0.85%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	1.87%
Enterprise Value to Invested Capital (EV/IC)	1.84	1.57	1.75	1.74	1.83	1.68	1.68	2.07	2.18	2.17	2.04
Enterprise Value to Revenue (EV/Rev)	1.70	1.50	1.58	1.33	1.33	1.26	1.35	1.46	1.88	2.02	1.76
Enterprise Value to EBITDA (EV/EBITDA)	9.24	8.56	13.03	9.43	13.82	22.05	36.18	70.14	20.99	15.31	8.43
Enterprise Value to EBIT (EV/EBIT)	21.59	21.30	102.27	37.83	0.00	0.00	0.00	0.00	0.00	54.27	15.18
Enterprise Value to NOPAT (EV/NOPAT)	26.73	26.00	144.54	92.11	66.83	78.00	56.58	74.67	50.28	0.00	49.02
Enterprise Value to Operating Cash Flow (EV/OCF)	10.59	9.17	13.75	9.67	9.28	9.17	10.54	13.16	17.07	18.07	12.71
Enterprise Value to Free Cash Flow (EV/FCFF)	20.23	16.51	30.98	8.50	5.14	4.57	7.71	10.55	0.00	0.00	20.43
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.87	0.95	0.92	0.72	0.96	1.09	1.21	1.05	1.29	1.27	1.29
Long-Term Debt to Equity	0.85	0.91	0.92	0.71	0.95	1.08	1.20	1.04	1.27	1.26	1.28
Financial Leverage	0.79	0.85	0.76	0.54	0.66	0.78	0.92	0.60	0.83	0.92	1.11
Leverage Ratio	3.05	2.96	3.04	2.96	3.05	3.04	3.30	3.27	3.38	3.32	3.70
Compound Leverage Factor	4.18	2.48	3.57	2.63	3.41	7.36	3.74	2.70	2.17	2.56	2.11
Debt to Total Capital	46.46%	48.69%	47.94%	41.73%	48.87%	52.08%	54.79%	51.15%	56.28%	55.99%	56.42%
Short-Term Debt to Total Capital	1.08%	2.10%	0.25%	0.28%	0.27%	0.28%	0.38%	0.50%	0.54%	0.58%	0.64%
Long-Term Debt to Total Capital	45.38%	46.59%	47.69%	41.45%	48.60%	51.81%	54.41%	50.66%	55.74%	55.41%	55.79%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	53.54%	51.31%	52.06%	58.27%	51.13%	47.92%	45.21%	48.85%	43.72%	44.01%	43.58%
Debt to EBITDA	2.45	2.82	3.82	2.63	4.69	8.40	12.56	19.89	5.61	4.13	2.50
Net Debt to EBITDA	2.18	2.49	3.31	2.26	4.29	7.66	11.27	17.75	5.11	3.81	2.20
Long-Term Debt to EBITDA	2.40	2.70	3.80	2.62	4.66	8.36	12.47	19.70	5.56	4.09	2.47
Debt to NOPAT	7.10	8.57	42.41	25.72	22.65	29.72	19.64	21.17	13.45	-2.29	14.52
Net Debt to NOPAT	6.31	7.57	36.74	22.05	20.75	27.10	17.63	18.90	12.24	-2.11	12.81
Long-Term Debt to NOPAT	6.93	8.20	42.19	25.54	22.53	29.56	19.51	20.97	13.32	-2.27	14.36
Altman Z-Score	2.09	2.16	1.98	2.05	1.86	1.98	1.81	2.01	2.23	2.38	2.07
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.17%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.64	0.76	0.70	0.60	0.68	0.70	0.54	0.52	0.57	0.66	0.55
Quick Ratio	0.49	0.60	0.54	0.47	0.32	0.38	0.36	0.35	0.40	0.46	0.40
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	31	114	35	352	463	541	260	254	-134	-115	22
Operating Cash Flow to CapEx	-501.81%	66.69%	680.68%	948.86%	-409.91%	-5.69%	636.06%	974.67%	-611.72%	-36.34%	1,098.16%
Free Cash Flow to Firm to Interest Expense	4.84	12.22	3.02	33.35	40.84	41.85	19.53	22.30	-10.45	-7.92	1.55
Operating Cash Flow to Interest Expense	-14.20	1.47	11.28	21.15	-7.26	-0.09	8.10	16.06	-6.94	-0.37	10.43
Operating Cash Flow Less CapEx to Interest Expense	-17.03	-0.74	9.62	18.92	-9.04	-1.65	6.82	14.41	-8.07	-1.37	9.48
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.63	0.64	0.62	0.62	0.64	0.66	0.66	0.64	0.65	0.65	0.64
Accounts Receivable Turnover	7.36	7.48	7.39	6.29	9.12	9.63	8.68	7.01	10.57	10.66	9.86
Inventory Turnover	19.20	18.99	19.35	20.58	21.21	20.47	20.49	20.36	18.95	16.89	16.53
Fixed Asset Turnover	7.83	7.91	7.84	7.79	8.23	8.30	8.46	8.52	8.94	8.91	9.14
Accounts Payable Turnover	11.92	14.44	12.93	8.56	13.46	13.95	16.30	8.28	12.92	10.87	9.04
Days Sales Outstanding (DSO)	49.61	48.80	49.36	58.01	40.01	37.90	42.03	52.06	34.54	34.25	37.03
Days Inventory Outstanding (DIO)	19.01	19.22	18.86	17.74	17.21	17.83	17.81	17.93	19.26	21.62	22.08
Days Payable Outstanding (DPO)	30.62	25.27	28.23	42.63	27.12	26.17	22.40	44.07	28.26	33.56	40.39
Cash Conversion Cycle (CCC)	38.00	42.75	39.99	33.12	30.10	29.56	37.45	25.92	25.54	22.31	18.72
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,917	1,982	1,846	1,543	1,443	1,473	1,553	1,320	1,574	1,641	1,468
Invested Capital Turnover	1.07	1.02	1.08	1.20	1.18	1.14	1.14	1.31	1.21	1.13	1.13
Increase / (Decrease) in Invested Capital	-43	-69	-82	-286	-474	-509	-293	-222	132	168	-86
Enterprise Value (EV)	3,536	3,104	3,222	2,680	2,643	2,474	2,612	2,732	3,435	3,561	2,994
Market Capitalization	2,701	2,200	2,403	2,039	1,822	1,614	1,798	2,040	2,599	2,676	2,211
Book Value per Share	$19.41	$19.35	$18.48	$18.85	$16.95	$15.71	$13.64	$13.51	$13.11	$13.91	$12.68
Tangible Book Value per Share	($19.78)	($18.87)	($18.80)	($18.28)	($14.88)	($15.30)	($17.81)	($17.67)	($18.29)	($17.42)	($17.88)
Total Capital	2,021	2,101	1,972	1,793	1,833	1,810	1,655	1,514	1,632	1,716	1,572
Total Debt	939	1,023	946	748	896	943	907	775	919	961	887
Total Long-Term Debt	917	979	941	743	891	938	901	767	910	951	877
Net Debt	835	904	819	642	821	859	814	691	836	885	783
Capital Expenditures (CapEx)	18	21	19	24	20	20	17	19	15	15	13
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-363	-226	-351	-456	-298	-263	-415	-495	-370	-257	-417
Debt-free Net Working Capital (DFNWC)	-258	-108	-225	-349	-223	-180	-322	-412	-287	-181	-312
Net Working Capital (NWC)	-280	-152	-230	-354	-228	-185	-328	-419	-296	-191	-322
Net Nonoperating Expense (NNE)	5.96	7.20	25	-2.50	81	52	81	6.91	-0.37	13	-41
Net Nonoperating Obligations (NNO)	835	904	819	498	505	606	805	581	861	885	783
Total Depreciation and Amortization (D&A)	58	52	52	50	44	40	45	48	37	37	36
Debt-free, Cash-free Net Working Capital to Revenue	-17.41%	-10.95%	-17.22%	-22.57%	-15.04%	-13.40%	-21.49%	-26.43%	-20.25%	-14.59%	-24.48%
Debt-free Net Working Capital to Revenue	-12.40%	-5.21%	-11.02%	-17.29%	-11.25%	-9.16%	-16.67%	-21.98%	-15.73%	-10.30%	-18.34%
Net Working Capital to Revenue	-13.45%	-7.34%	-11.27%	-17.54%	-11.50%	-9.42%	-17.00%	-22.38%	-16.21%	-10.86%	-18.93%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.32)	$0.69	($1.29)	$1.23	($1.67)	($0.35)	($2.08)	$0.45	($0.03)	$0.75	($0.43)
Adjusted Weighted Average Basic Shares Outstanding	55.74M	55.62M	55.51M	55.56M	55.27M	55.10M	54.81M	54.95M	54.38M	54.19M	53.95M
Adjusted Diluted Earnings per Share	($0.32)	$0.68	($1.29)	$1.24	($1.67)	($0.35)	($2.08)	$0.45	($0.03)	$0.74	($0.43)
Adjusted Weighted Average Diluted Shares Outstanding	55.74M	56.20M	55.51M	56.36M	55.27M	55.10M	54.81M	54.95M	54.38M	54.85M	53.95M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	55.70M	55.56M	55.45M	55.28M	55.21M	54.87M	54.73M	54.43M	54.28M	54.03M	53.85M
Normalized Net Operating Profit after Tax (NOPAT)	3.83	56	29	69	16	50	35	56	23	56	40
Normalized NOPAT Margin	0.79%	10.96%	5.92%	13.15%	3.49%	10.13%	7.62%	11.92%	5.69%	13.13%	9.93%
Pre Tax Income Margin	-4.80%	9.39%	-15.76%	16.27%	-23.66%	-4.47%	-24.37%	11.53%	5.70%	11.47%	4.61%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-2.69	6.18	-5.72	9.11	-8.42	-0.70	-7.43	5.73	2.80	4.38	2.33
NOPAT to Interest Expense	-1.88	4.86	-4.07	6.23	-1.01	2.50	-2.44	2.82	-0.14	3.67	-4.54
EBIT Less CapEx to Interest Expense	-5.52	3.97	-7.38	6.88	-10.19	-2.27	-8.70	4.08	1.66	3.38	1.38
NOPAT Less CapEx to Interest Expense	-4.71	2.66	-5.73	4.01	-2.78	0.94	-3.71	1.17	-1.28	2.66	-5.49
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	66.33%	78.22%	-971.40%	448.55%	-135.00%	-67.26%	-49.03%	-38.42%	-70.11%	-154.35%	184.69%
Augmented Payout Ratio	94.30%	108.70%	-1,337.16%	651.65%	-196.19%	-102.10%	-74.47%	-60.91%	-113.54%	-251.08%	309.22%

Frequently Asked Questions About John Wiley & Sons' Financials

When does John Wiley & Sons's fiscal year end?

According to the most recent income statement we have on file, John Wiley & Sons' financial year ends in April. Their financial year 2024 ended on April 30, 2024.

How has John Wiley & Sons' net income changed over the last 9 years?

John Wiley & Sons' net income appears to be on a downward trend, with a most recent value of -$200.32 million in 2024, falling from $176.87 million in 2015. The previous period was $17.23 million in 2023.

What is John Wiley & Sons's operating income?

John Wiley & Sons's total operating income in 2024 was $52.26 million, based on the following breakdown:

Total Gross Profit: $1.29 billion
Total Operating Expenses: $1.24 billion

How has John Wiley & Sons revenue changed over the last 9 years?

Over the last 9 years, John Wiley & Sons' total revenue changed from $1.82 billion in 2015 to $1.87 billion in 2024, a change of 2.8%.

How much debt does John Wiley & Sons have?

John Wiley & Sons' total liabilities were at $1.99 billion at the end of 2024, a 3.8% decrease from 2023, and a 1.9% increase since 2015.

How much cash does John Wiley & Sons have?

In the past 9 years, John Wiley & Sons' cash and equivalents has ranged from $58.52 million in 2017 to $457.44 million in 2015, and is currently $83.25 million as of their latest financial filing in 2024.

How has John Wiley & Sons' book value per share changed over the last 9 years?

Over the last 9 years, John Wiley & Sons' book value per share changed from 17.97 in 2015 to 13.51 in 2024, a change of -24.8%.

Related Companies

This page (NYSE:WLYB) was last updated on 4/18/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

John Wiley & Sons (WLYB) Financials

Frequently Asked Questions About John Wiley & Sons' Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

John Wiley & Sons (WLYB) Financials

Annual Income Statements for John Wiley & Sons

Quarterly Income Statements for John Wiley & Sons

Annual Cash Flow Statements for John Wiley & Sons

Quarterly Cash Flow Statements for John Wiley & Sons

Annual Balance Sheets for John Wiley & Sons

Quarterly Balance Sheets for John Wiley & Sons

Annual Metrics and Ratios for John Wiley & Sons

Quarterly Metrics and Ratios for John Wiley & Sons

Frequently Asked Questions About John Wiley & Sons' Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools